Concurent Chemoradiotherapy in Head and Neck Cancers

Summary

To compare the efficacy and toxicities of the combination between weekly docitaxel and cisplatin (every3 week) concurrent with radiation versus the standard concurrent chemoradiotherapy with high dose cisplatin (100mg\\m2) for locally advanced HNSCC

Timeline

Start

2021-04-01

Primary completion

2022-04-01

Completion

2022-09-01

Drugs

Indications